Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism.
Wang HW, Yang SH, Huang GD, Lin JK, Chen WS, Jiang JK, Lan YT, Lin CC, Hwang WL, Tzeng CH, Li AF, Yen CC, Teng HW.
Wang HW, et al. Among authors: jiang jk.
J Cancer Res Clin Oncol. 2014 Apr;140(4):561-71. doi: 10.1007/s00432-014-1596-4. Epub 2014 Feb 4.
J Cancer Res Clin Oncol. 2014.
PMID: 24493623